Synergistic Bioactive Systems for Enhanced Immune Response and Health Monitoring

Publication ID: 24-11857587_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Bioactive Systems for Enhanced Immune Response and Health Monitoring,” Published Technical Disclosure No. 24-11857587_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857587_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,587.

Summary of the Inventive Concept

The present invention discloses novel synergistic combinations of bioactive extracts from medicinal fungal species with distinct technologies, including AI, IoT, blockchain, and new materials, to create powerful systems for immune system support, health monitoring, and antimicrobial resistance tracking.

Background and Problem Solved

The original patent relates to a composition including fungal extract components from one or more medicinal fungal species, providing antiviral, antibacterial, antifungal, antiprotozoal, and immune-boosting activities. However, there is a need for more advanced systems that integrate these bioactive extracts with other technologies to enhance their efficacy and provide real-time health monitoring and data analysis capabilities.

Detailed Description of the Inventive Concept

The new inventive concept comprises four distinct systems: 1) a bioactive extract-based system for monitoring and optimizing immune system responses, incorporating an AI-powered analytics module; 2) a personalized health monitoring method integrating a bioactive extract with a wearable IoT device and a blockchain-based data storage system; 3) a composition for immune system support featuring a synergistic combination of a bioactive extract, a native Australian bush food extract, and a graphene-based nanomaterial for enhanced bioavailability and targeted delivery; and 4) a system for antimicrobial resistance tracking, comprising a bioactive extract, a machine learning algorithm, and a cloud-based data repository.

Novelty and Inventive Step

The new claims introduce novel synergistic combinations of bioactive extracts with AI, IoT, blockchain, and new materials, providing enhanced functionality, real-time data analysis, and secure data management. These combinations are non-obvious and represent a significant advancement over the original patent.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept may include the use of different medicinal fungal species, varying ratios of bioactive extract to native Australian bush food extract, or the integration of additional technologies, such as robotics or 3D printing, to further enhance the systems' capabilities.

Potential Commercial Applications and Market

The inventive concept has significant commercial potential in the healthcare and wellness industries, particularly in the areas of immune system support, health monitoring, and antimicrobial resistance tracking. Target markets may include pharmaceutical companies, healthcare providers, and wellness centers.

CPC Classifications

SectionClassGroup
A A61 A61K36/074
A A61 A61K36/185
A A61 A61K2236/333

Original Patent Information

Patent NumberUS 11,857,587
TitleBioactive extract